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Secondary plasma cells (PCs) originate from memory B cells and produce increased
levels of antibodies with higher affinity compared to PCs generated during primary
responses. Here we demonstrate that virus-like particles (VLPs) only induce secondary
PCs in the presence of toll-like receptor (TLR) 7 and if they are loaded with RNA.
Furthermore, adoptive transfer experiments demonstrate that RNA and TLR7 signaling
are required for secondary PC generation, both at the level of memory B cell as well as PC
differentiation. TLR7-signaling occurred in a B cell intrinsic manner as TLR7-deficient B
cells in an otherwise TLR7-competent environment failed to differentiate into secondary
PCs. Therefore, RNA inside VLPs is essential for the generation of memory B cells, which
are competent to differentiate to secondary PCs and for the differentiation of secondary
PCs themselves. While we have not tested all other TLR or non-TLR adjuvants with our
VLPs, these data have obvious implications for vaccine design, as RNA packaged into
VLPs is a simple way to enhance induction of memory B cells capable of generating
secondary PCs.
Keywords: memory B cells, secondary plasma cells, virus-like particles, toll-like receptor 7, anti-viral immunity,
adaptive immunity
INTRODUCTION
Antibodies are the critical effector molecules induced by prophylactic vaccination and are
responsible for anti-viral and anti-bacterial protection. PCs are the principle cell type producing
antibodies. A number of different antibody forming cells (AFCs) have been described. At an early
stage of the primary immune response, short-lived AFCs derived frommarginal zone or follicular B
cells are found in extra-follicular foci in secondary lymphoid structures (1). A second wave of PCs
is generated by the germinal center (GC) reaction of which some are also short-lived. However, a
subset of GC derived PCs is long-lived and resides in secondary lymphoid organs as well as bone
marrow (BM) for months and even years (2–4). It has been known for decades that memory B cells
can differentiate to PCs after secondary antigen encounter (5, 6). We have recently described the
particular phenotype of these PCs, which we coined secondary PCs, as they derive from memory
B cells during secondary responses, in a VLP immunization model (7). In contrast to PCs induced
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during primary responses, they produce increased levels of high
affinity antibodies. Unexpectedly, secondary PCs are short-lived
and disappear a few days after their induction (Martin et al.,
Under review).
The Th cell dependence of PC induction varies with the type
of B cell progenitor. B1 cells, which provide only 1% of splenic
B cells and are usually found in the peritoneal and pleural cavity,
are a major source of natural antibodies produced in a Th cell
independent manner (8). Early extra-follicular PCs, which often
produce IgM, may be induced in the absence of T cell help in
many cases, in particular if Th cell independent antigens are
used for immunization (9). In contrast, GC-derived PCs are
often isotype-switched and their generation requires T cell help
and CD40L (10, 11). As opposed to GC-derived primary PCs,
secondary PCs derived from memory B cells can be induced
in the absence of CD40L (12). Hence, secondary PCs provide
an early wave of antibodies in a relatively Th cell independent
fashion during secondary responses, in a way similar to the short-
lived extra-follicular PCs induced during primary responses.
Most antibody responses are driven by follicular Th cells
(13, 14). However, presence of TLR-ligands, such as RNA, may
overcome the requirement of follicular Th cells and other Th cells
may take over (15–21).
There is a large number of adjuvants that are able to
induce strong and long-lived B cell and antibody responses
(22). Even though TLR-ligands are potent enhancers of B cell
responses (23, 24), there is not an absolute requirement for the
presence of TLR-ligands in order to induce protective B cell
responses. Nevertheless, TLR-ligands play an important role for
the generation of antibody responses during natural infections
and many natural or artificial TLR-ligands are in development
for adjuvants formulation (25–28) often in combination with
classical adjuvants such as Alum (29). Monophosphoryl lipid A
(MPL), a synthetic TLR4-ligand, is part of marketed vaccines
since decades (30–32) and CpGs, a synthetic ligand for TLR9,
have recently been approved for use in combination with
hepatitis B vaccine (33). Furthermore, natural TLR-ligands are
components of many widely used vaccines; in particular RNA,
which is part of almost all live and inactivated viral and bacterial
vaccines (34, 35). Single stranded RNA (ssRNA) is recognized
by TLR7/8 in the endosome and RNA-sensing molecules in
the cytosol and enhances antibody responses in many ways.
B cells recognize RNA associated with the antigen via TLR7/8
and respond with increased production of IgG and in particular
with a shift to the IgG2a subclass (17, 36, 37), enhanced B
cell proliferation and increased BCR hypermutation (38, 39).
This mechanism is dependent on TLR7-signaling in B cells and
independent of RNA sensing in DCs (17). Similar B cell intrinsic
pathways have been described for TLR9 (36, 37) which drives
antibody responses in an IRF5-dependent way (40) and promotes
B cell survival (28). The IgA subclass is particularly interesting
with respect to TLR7-signaling, as systemic IgA responses need
TLR signaling in B cells, while mucosal IgA responses need
TLR signaling in DCs (41, 42). In addition, it has recently
been shown that IgG responses against gram-negative bacteria
require RNA-sensing in DCs followed by activation of TRIF and
further downstream the inflammasome pathway (35, 43). The
requirement for B cell intrinsic TLR signaling varies with time
and is more important early than late during the GC response
(34, 39), a finding that is consistent with the fact that the early
GC response is more important than the late response to drive
long-lived antibody responses (44). Furthermore, recent work
indicated a temporal switch in GC reactions, where memory B
cells are shown to emerge early during the response, whereas long
lived PCs are a late output of the GC (20).
We have previously shown that immunization with VLPs
derived from the RNA bacteriophage Qβ elicits strong and
sustained IgG antibody responses with a prominent role for
packaged E.coli RNA in driving class switch to IgG2a and IgA
antibodies (42, 45–47). During recall responses, MBCs rapidly
and quantitatively differentiate into secondary PCs (7). Here
we show that RNA and TLR7-signaling in B cells synergize
for the regulation of the secondary PC response. Absence of
RNA or TLR7-signaling resulted in complete failure to generate
memory B cells competent of forming secondary PCs. Moreover,
stimulation of memory B cells generated in the presence of RNA,
also failed to result in secondary PC induction in the absence
of TLR7-signaling during recall. Hence, generation of secondary
PCs is regulated by RNA and TLR7-signaling at multiple levels.
MATERIALS AND METHODS
Study Design
The goal of this study was to further characterize secondary
PCs, which were generated by MBCs after Ag challenge. To
achieve this, adoptive transfers in allotypic mice (Ly5.1/Ly5.2,
IgHa/IgHb, TLR7 KO/WT, and TLR7 KO BM chimeras/WT BM
chimeras) were performed. This enabled us to study primary and
secondary immune responses in the same animal. All mice were
kept according to cantonal veterinary guidelines at the central
animal facility (Department of Biomedical Research) of the
University of Bern and controlled laboratory experiments were
performed in accordance with ethical principles and guidelines
of the Cantonal Veterinary Office Bern, Switzerland. Animals
were randomly assigned to the different groups. MBCs were
generated by VLP immunization of mice. The control naïve mice
remained untreated. At the same time, B cells were isolated from
memory and naive mice and transferred into recipients. Upon
immunization with VLPs, serum samples, spleens, and BM were
collected and subjected to ELISA, ELISPOT, and FCM analysis.
The investigators who performed the experiments, assessed,
analyzed, and quantified the results were not blinded and aware
of which group a sample was taken from. Individual groups
consisted of four mice. All experiments were performed in at
least two independent biological replicates. For the ELISA and
ELISPOT in Figures 1D,E and day 6 FCM experiment only
one replicate was performed. Data were collected at previously
determined time points. All data were included in the analysis.
Mice
C57BL/6JRccHsd wildtype mice were purchased from Envigo
(Horst, The Netherlands). The IgHa [B6.Cg-Gpi1<a> Thy1<a>
Igh<a> (Stock No. 001317)] mouse strain was purchased
from the Jackson Laboratory (USA). We thank Prof. Annette
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FIGURE 1 | Memory B cells generated in presence of bacterial RNA generate secondary PCs after challenge with VLPs containing RNA. (A) Congenic mice (Ly5.1 or
IgHa) were immunized with 50 µg Qβ VLPs containing RNA (B,E,F) or polyglutamic acid (PGA) (C–E,G) i.v. Eight weeks after immunization spleens of immunized and
naïve mice were isolated and PNA− B220+ (B,C,E–G) and CD4+ (D) MACS purified cells were transferred into host mice (Ly5.2 or IgHb). Recipient mice were
immunized with 50 µg Qβ-RNA or Qβ-PGA i.v. 1 day after the transfer. Spleens, bone marrow, and serum were taken at several time points after challenge. (B,C) The
anti-Qβ IgG1 and IgG2a antibody titers in the serum were determined by ELISA. Ha and Hb allotype specific detection antibodies were used to discriminate between
donor (IgHa, gray circles) and host (IgHb, black squares) responses. (D) The endpoint titer of anti-Qβ IgG1 and IgG2a antibodies in the serum was determined by
ELISA. Donor-derived responses after memory B cell (black open circles) or memory B cell and memory CD4+ T cell (gray open circles) transfer were detected using
(Continued)
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FIGURE 1 | Ha allotype specific detection antibodies. (E) Quantification of the spot diameter in ELISPOT assays after transfer of memory B cells induced with 50 µg
Qβ-RNA (black circles) or Qβ-PGA (open circles) and challenge with 50 µg Qβ-RNA. A modified ELISA was performed to determine the avidity index of the sera after
transfer of memory B cells generated in presence (F) or absence (G) of bacterial RNA. Mean with SEM. P-values were obtained using an unpaired t-test. *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001. n = 4 mice per group. Data representative of 2 independent experiments, except for D and E, where only one experiment
was performed.
Oxenius for the kind donation of the Ly5.1 (B6.SJL-Ptprc<a>
Pepc<b>/BoyJ) mouse strain, Prof. Dr. Pål Johansen for the kind
donation of the TLR7 KO (B6.129P2-Tlr7tm1Aki) mouse strain
and Prof. Andrew Macpherson for the kind donation of the JH
KO (B6.129P2-Igh-Jtm1Cgn/J) mouse strain.
Generation of BM Chimeras
C57BL/6JRccHsd wildtype mice were lethally irradiated by the
application of 1,300 cGy as a split dose of 2 × 650 cGy with a
4 h interval, using a Gammacell 40 (GC40) research irradiator
(Best Theratronics). Irradiated mice were reconstituted with 25
× 107 donor bone marrow cells, consisting of 80% JH KO and
20% TLR7 KO or 20% C57BL/6JRccHsd WT cells, respectively,
i.v. Antibiotics [Baytril (1.25 ml/l) and Bactrim Nopil (5 ml/l)]
were supplied in the drinking water for 2 weeks. After 6 weeks,
reconstitution of the BM chimeras was analyzed by staining of B
cell (B220) and T cell (CD3) markers using FCM. BM chimeras
were immunized with 50 µg Qβ VLPs formulated in 150 µl
phosphate buffer intravenously 10 weeks after irradiation.
Antigen
The bacteriophage derived Qβ virus-like particles (VLPs) self-
assemble and enclose bacterial RNA during their production
in E. coli. The purification process is described elsewhere
(48). VLPs without RNA were generated by disassembling the
particles in presence of DTT in acidic conditions. This results
in dimer formation, which were purified by size exclusion
chromatography. Afterwards, the dimers were reassembled with
polyglutamic acid (PGA) (17). VLPs containing B type CpGs
(1668) were prepared as described previously (49, 50). Briefly,
RNA inside the VLPs was digested using RNAse A (1.2 mg/ml
for 3 mg/ml VLPs) for 3 h at 37◦C. RNA digestion was confirmed
using a 1% agarose gel stained with peqGreen dye. VLPs were
repackaged by adding 1.125 µg CpG oligonucleotides to 20 µg
RNAse digested VLPs for 3 h at 37 ◦C and repackaging was
confirmed on a 1% agarose gel.
Immunization
To induce primary immune responses and generate memory
B cells against the VLPs, mice were immunized intravenously
(i.v.) with 50 µg Qβ-RNA or Qβ-PGA. To challenge adoptively
transferred MBC or naive cells, recipient mice were immunized
with 50 µg of either Qβ-RNA, Qβ-PGA or Qβ-CpG i.v.
For administration the VLPs were formulated in 150 µl
phosphate buffer.
Adoptive Transfer
MBCs were generated by immunization of congenic donor
mice (Ly5.1, IgHa, TLR7 KO, WT, or BM chimeras). At
least 8 weeks after immunization donor mice were sacrificed
and spleens isolated in RPMI media containing 2% FCS and
antibiotics. A single cell suspension of the spleens was prepared
and red blood cells were lysed using ACK buffer (0.15M
ammonium chloride, 0.01M potassium hydrogen carbonate,
pH 7.2–7.4). The splenocytes were PNA− and B220+ MACS
purified. For PNA negative purification splenocytes were labeled
using PNA-biotin (Vector Labs, B-1075) and PNA+ cells were
depleted by Strepravidin MicroBeads (Milteny Biotec, 130-
048-101) according to the manufacturer’s protocol. Positive
selection using B220 and CD4 MicroBeads (Milteny Biotec,
130-049-501, 130-117-043) was performed according to the
manufacturer’s protocol.
Purified cells from 1/3 of a donor spleen (Ly5.1, IgHa, TLR7
KO, WT, or BM chimeras ∼1–3 × 106 cells of which ∼0.05–
0.1% are specific for the antigen) were adoptively transferred
i.v. into congenic host mice (Ly5.1, Ly5.2, or IgHb). Control
mice received PNA− and B220+ purified splenocytes from naïve
congenic mice. One day after memory B cell transfer host mice
were challenged with 50 µg of either Qβ-RNA, Qβ-PGA or
Qβ-CpG i.v. formulated in 150 µl phosphate buffer.
ELISPOT
Spleens from mice after adoptive transfer were isolated and a
single cell suspension was prepared. To collect BM cells, tibia
and femur were flushed with RPMI media containing 2% FCS
and antibiotics. After red blood cell lysis with ACK buffer, cell
numbers of splenocytes and BM cells were determined using the
Cellometer mini (Nexcelom, USA). 5 × 105 cells were seeded
per well on MAIPS ELISPOT plates (Millipore, MAIPS4510)
previously coated with 10µg/ml Qβ VLPs overnight at 4◦C and
blocked with 2% BSA in PBS for at least 2 h. After performing
a 2-fold dilution series, cells were incubated for 5 h at 37◦C
and 5% CO2. Subsequently cells were washed off and bound
specific antibodies produced by PCs were detected using a goat
anti-mouse IgG antibody (EY laboratories, AT-2306-2) followed
by a donkey anti-goat alkaline phosphatase secondary antibody
(Jackson Immunoresearch, 705-055-147). Spots were visualized
by the AP Conjugate Substrate Kit (BioRad, 1706432) and
counted using an EliSpot Reader (AID, Germany).
ELISA
Serum samples were obtained from blood collected at the
indicated time points during experiments using Microtainer
tubes (BD, 365967). Corning half area 96 well plates were coated
with 1µg/ml Qβ VLPs overnight at 4◦C. Sera were 1:10 pre-
diluted and 1:4 further serial diluted to analyse a total of 7
dilutions per sample. Qβ-specific antibodies were detected using
mouse anti-mouse IgG for both allotypes. IgHa-specific (biotin
ms anti-ms IgG1[a] (10.9), biotin ms anti-ms IgG2a[a] (8.3)
from BD) and IgHb-specific (biotin ms anti-ms IgG1[b] (B68-
2), biotin ms anti-ms IgG2a[b] (5.7) from BD) antibodies were
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detected using horseradish peroxidase (HRP) labeled streptavidin
(Jackson ImmunoResearch, 016-030-084).
Total Qβ-specific antibodies were detected using goat anti-
mouse IgG-HRP (Jackson ImmunoResearch, 115-035-071).
The absorbance readings of the tetramethylbenzidine (TMB)
color reaction at 450 nm for the serum samples were interpreted
as OD50 or endpoint antibody titers. The OD50 antibody titers
are defined as the reciprocal of the dilution that reaches half of
the maximal optical density (ODmax). The endpoint antibody
titers are defined as the reciprocal of the last dilution above the
threshold, which is set above the background level.
Avidity ELISA
Serum samples were obtained from blood collected at the
indicated time points during experiments using Microtainer
tubes (BD, 365967). Corning half area 96 well plates were coated
with 1µg/ml Qβ VLPs overnight at 4◦C. Sera of the different
time points were applied with a 1:10 pre-dilution and 1:4 further
serial diluted. After 1 h incubation, the sera were washed off
and the plates washed 3 times 5min either with 7M urea in
PBST (PBS containing 0.05%Tween20) or PBST only. Qβ specific
antibodies were detected using mouse anti-mouse IgG for both
allotypes. IgHa-specific (biotin ms anti-ms IgG1[a] (10.9), biotin
ms anti-ms IgG2a[a] (8.3) from BD) and IgHb-specific (biotin
ms anti-ms IgG1[b] (B68-2), biotin ms anti-ms IgG2a[b] (5.7)
from BD) antibodies were detected using horseradish peroxidase
(HRP) labeled streptavidin (Jackson ImmunoResearch, 016-030-
084). Total Qβ-specific antibodies were detected using goat anti-
mouse IgG-HRP (Jackson ImmunoResearch, 115-035-071). The
absorbance readings of the tetramethylbenzidine (TMB) color
reaction at 450 nm served as basis for avidity index calculation.
The avidity index (AI) was calculated by AIx = OD (dilution x)
+ urea/OD (dilution x)–urea.
Flow Cytometry (FCM)
For FCM staining spleens of mice after adoptive transfer were
isolated in RPMI supplemented with 2% FCS and antibiotics
and a single cell suspension was prepared. Red blood cells
were lysed using ACK buffer prior to staining. Fc receptors
were blocked using an anti-CD16/32 antibody (2.4G2, BD). To
discriminate Qβ-specific plasma cells (PCs) from Qβ-specific
activated and CS B cells, surface immunoglobulins (Ig) of specific
cells were blocked using unlabelled Qβ VLPs. PCs were further
stained with and characterized as IgM (polyclonal, Jackson
ImmunoResearch), IgD (11-26c (11-26), eBioscience), CD4
(H129.19, BD), CD8 (53-6.7, BD), GR1 (RB6-8C5, BD), CD11b
(M1/70, BD), CD11c (HL3, BD) negative (all antibodies labeled
with PE), and B220-PE-Cy7 (RA3-6B2, BD) low. To detect Qβ
specific PCs by intracellular staining of specific Ig, splenocytes
were permeabilized using FACS lysing solution (BD, 349202)
containing 0.04% Tween20 and stained with Alexa Flour 488
labeled Qβ VLPs. The congenic marker Ly5.1 (antibody labeled
with APC, A20, eBioscience) identified all transfer derived B cells.
Qβ VLPs were labeled with the Alexa Flour 488 protein
labeling kit (Thermo Fisher Scientific, A10235) according to the
manufacturer’s instructions.
Statistics
Statistical analysis was performed using GraphPad Prism
Version 7.01 (GraphPad Software, USA). Statistically significant
differences between two groups were calculated using unpaired
t-tests. Statistical significance was defined as p < 0.05.
RESULTS
RNA Drives the Generation of Memory B
Cells Competent of Forming
Secondary PCs
We have previously demonstrated that vaccination with Qβ
VLPs containing bacterial RNA leads to the formation of
long-lasting humoral memory. Upon immunization, isotype-
switched memory B cells as well as PCs are generated in a
Th cell-dependent manner (7, 12, 44, 45). During secondary
responses, VLP specific memory B cells do not re-enter GCs
but differentiate to short-lived secondary PCs independent of T
cell help (7, 12). The hallmark of secondary PCs is increased
production of high affinity antibodies early after activation
(Martin et al., Under review). To further study the mechanism
of secondary PC generation, adoptive transfers of memory B
cells using congenic mice were performed. Briefly, memory
B cells were generated by immunizing wildtype (WT) donor
mice with Qβ VLPs containing either bacterial RNA (Qβ-RNA)
or polyglutamic acid (Qβ-PGA), a negatively charged polymer
serving as surrogate for RNA to enable VLP-assembly, which,
however, does not stimulate TLRs (Figure 1A). Purified memory
B cells of immunized or naïve donor mice were transferred
into congenic recipient mice expressing a different IgH- or
Ly5- allotype. We did not co-transfer memory CD4+ T cells
after Qβ-RNA priming, as we have previously observed that
their presence has no influence on VLP specific memory B
cell responses (7, 12). Upon cell transfer and challenge with
Qβ-RNA the specific VLP antibody response of transferred
memory B cells and host B cells was assessed within recipient
mice (Figures 1B,C). As observed before, when memory B
cells were induced with Qβ-RNA and challenged with Qβ-
RNA, the on- and offset as well as the magnitude of the
antibody response derived frommemory B cells was significantly
faster and higher compared to the host’s primary antibody
response (Figure 1B). Memory B cell derived IgG titers raised
within 4 days and peaked early at day 6 post-immunization.
In contrast, the host’s primary response became detectable on
day 6 and peaked at day 12 after immunization. However, if
memory B cells were generated with Qβ-PGA instead of Qβ
containing RNA, memory B cell derived antibody responses
were not increased but rather similar to the host‘s antibody
response after challenge with Qβ-RNA (Figure 1C; Figure S1A).
Therefore, the memory antibody response resembled the one of
the primary response if VLPs deprived of RNA were used for
memory B cell generation indicating that RNA inside the VLPs
was crucial for enhanced antibody responses during secondary
Ag challenges. A similar donor response was seen when Qβ-
PGA memory B cells were transferred in presence or absence
of memory CD4+ T cells (Figure 1D) and challenged with
Frontiers in Immunology | www.frontiersin.org 5 April 2019 | Volume 10 | Article 736
Krueger et al. TLR7-Signaling in Secondary PC Generation
FIGURE 2 | Presence of bacterial RNA during challenge of memory B cells is essential to generate secondary PCs. Memory B cells were generated by immunizing
Ly5.1 mice (donor) with 50 µg Qβ-RNA. One day after transfer of MACS purified memory B cells, allotypic Ly5.2 hosts were challenged with 50 µg Qβ-RNA or 50 µg
Qβ-PGA, respectively. (A) Representative FCM plots for the gating strategy to identify Qβ-specific PCs in the spleen 5 days after transfer and challenge. B220low cells
not expressing IgM, IgD, CD4, CD8, CD11b, CD11c, or GR1 were analyzed for their intracellular binding of labeled Qβ VLPs. The congenic Ly5 marker was used to
discriminate transfer from host derived PCs. (B,C) FCM analysis of the specific PC compartment at day 4, 5, and 6 after transfer of memory B cells induced with
Qβ-RNA and challenged with Qβ-RNA (black circles) or Qβ-PGA (gray circles). Number of Qβ-specific donor (B) or host (C) derived PCs within the B220low, IgM, IgD,
(Continued)
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FIGURE 2 | CD4, CD8, CD11b, CD11c, and GR1 negative compartment, binding Qβ intracellularly after membrane permeabilisation. Representative images of
ELISPOTs of the spleen at day 5 after Qβ-RNA memory B cell transfer and Qβ-RNA (D) or Qβ-PGA (E) challenge. (F) Numbers of Qβ-specific PCs in spleen and BM
4, 5, and 6 days after memory B cell transfer and challenge with either Qβ-RNA (black circles) or Qβ-PGA (open circles) were determined by ELISPOT. (G)
Quantification of the spot diameter in ELISPOT assays after memory B cell transfer and challenge with either Qβ-RNA (black circles) or Qβ-PGA (open circles). Mean
with SEM. P-values were obtained using an unpaired t-test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. n = 4 mice per group. Data representative of 2
independent experiments, except for day 6 of B and C, where only one experiment was performed.
Qβ-RNA. Consequently, like in Qβ-RNA secondary responses,
co-transfer of memory CD4+ T cells had no influence on
the VLP specific memory B cell response. Of note, memory
B cells generated with VLPs containing RNA also failed to
generate increased IgG levels if the boost was performed with
Qβ devoid of RNA (Figure S2A). Thus, enhanced IgG responses
were only detectable when memory B cells were generated
and boosted with Qβ-RNA (Figures 1B,C; Figures S1A, S2A-C).
The increased IgG response produced by memory B cells
generated in presence of RNA could also be verified in
ELISPOT assays of spleen and BM, where the spot diameter
correlates with the amount of antibodies produced by one
PC (Figure 1E).
We further investigated the antibody response by performing
avidity ELISAs (Figures 1F,G). The avidity index was determined
by a modified ELISA where washes with 7M urea were
performed, which dissociates low avidity antibodies but high
avidity antibodies remain bound. The avidity index of secondary
response antibodies after Qβ-RNA induced memory B cell
transfer and Qβ-RNA re-stimulation was high as of day
4 and stayed significantly higher compared to the primary
response antibodies until day 21 (Figure 1F). A similar, but
less pronounced, observation of the avidity increase was made,
when Qβ-PGA induced memory B cells were transferred and
re-stimulated with Qβ-RNA (Figure 1G). In strong contrast,
primary response antibodies reach comparable avidity only
after 21 days in the absence of memory B cell transfer
(Figure S1B). These data indicate that RNA is required to
generate memory B cells capable of generating secondary PCs
but affinity maturation occurred to a large degree in the absence
of RNA.
Presence of Bacterial RNA During
Challenge of Memory B Cells Is Essential
to Generate Secondary PCs
After induction of memory B cells with Qβ-RNA in Ly5 allotypic
wildtype mice, MACS purified memory B cells were adoptively
transferred into allotypic recipients, which were challenged with
Qβ-RNA or Qβ-PGA 1 day after transfer (Figure 1A). Antigen-
specific PCs were identified as B220low, IgM, IgD, CD4, CD8,
CD11b, CD11c, GR1 negative and by intracellular Qβ binding
after membrane permeabilisation using flow cytometry (FCM).
Donor derived cells (Ly5.1+) were discriminated from host
derived cells (Ly5.2+) using the Ly5 marker (Figure 2A). Donor,
hence memory B cell derived Qβ-specific PCs, were significantly
increased on day 4 and 5 after challenge with Qβ-RNA compared
to Qβ-PGA (Figure 2B). This difference was less prominent
looking at host derived antigen specific PCs generated early
during the primary response (Figure 2C).
The increased PC response generated by transferred memory
B cells boosted with Qβ-RNA in comparison to Qβ-PGA
correlated with PC numbers detectable in spleen and BM
analyzed by ELISPOT (Figures 2D–F). In addition, secondary
PCs generated in presence of Qβ-RNA were capable to produce
more antibodies shown by the increased spot diameter observed
in ELISPOT analysis (Figures 2D,E,G). The peak of the PC
number and spot diameter in spleen and BM after transfer of
Qβ-RNA-primed memory B cells followed by challenge with Qβ-
RNA was around day 4 and 5, thereafter PC numbers rapidly
declined, demonstrating the short-lived nature of the secondary
PCs. In contrast, boosting with Qβ-PGA resulted in slower but
more sustained responses (Figure 2B, day 6). The early PC
population detectable in spleen and BM after naïve cell transfer in
control experiments generating a primary response was smaller
and produced less antibodies (Figures S1C,D).
Thus, bacterial RNA as a TLR7 ligand is not only important
in the generation of memory B cells but also during their
differentiation to secondary PCs with increased ability to secrete
high-affinity antibodies.
RNA Induced TLR7 Signaling Must Be
Present for Induction of Memory B Cells
Competent to Differentiate Into
Secondary PCs
To assess whether TLR7 was involved in the generation of
memory B cells competent to differentiate into secondary
PCs, adoptive transfer experiments using TLR7 KO mice were
performed. Memory B cells were induced in TLR7 KO or
WT mice by Qβ-RNA vaccination. MACS purified memory B
cells were then transferred into Ly5-allotypic WT mice and
challenged with Qβ-RNA, Qβ-PGA, or Qβ-CpG (Figure 3A). As
observed with Qβ-PGA (Figures 1C,G), the total anti-Qβ IgG
titer and avidity was significantly lower at early time-points when
TLR7 deficient memory B cells were transferred (Figures 3B,C).
Therefore, the humoral immune responses observed in the
absence of TLR7 correlated well with the data observed in the
absence of RNA, indicating that memory B cells competent to
differentiate to secondary PCs fail to differentiate in the absence
of TLR7 signaling.
PC numbers and spot sizes in spleen and BM obtained
from ELISPOT assays were consistent with the antibody
responses and corroborated the findings using RNA-free VLPs
(Figures 3D,E). Host mice that received WT memory B cells
exhibited significantly increased PC frequencies in the spleen
5 days after VLP challenge (Figure 3D). This difference was
less prominent in the BM. The spot diameter was significantly
increased in spleen and BM after WT memory B cell transfer
compared to TLR7 KO memory B cell transfer early during the
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FIGURE 3 | TLR7 must be present during memory B cell induction to generate secondary PCs after challenge with VLPs. (A) Memory B cells were induced in TLR7
KO, WT, or BM chimeras by immunization with 50 µg Qβ-RNA i.v. Eight weeks after immunization spleens were isolated and PNA− B220+ MACS purified cells were
transferred into host mice (Ly5.1). One day after the transfer, recipient mice were challenged with 50 µg Qβ-RNA (B–E) or Qβ-RNA, Qβ-PGA, and Qβ-CpG (F,G) i.v.
Spleens, bone marrow, and serum were taken at several time points after challenge. (B) Qβ-specific total IgG titers after WT (black squares) or TLR7 KO (open circles)
memory B cell transfer were determined by ELISA. (C) The avidity index after WT (black circles) or TLR7 KO (open circles) memory B cell transfer was determined by a
(Continued)
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FIGURE 3 | modified ELISA. (D,E) ELISPOT assays were used to determine the number (D) of Qβ specific PCs and the spot diameter (E) produced by these in
spleen and BM on days 5 and 21 after WT (black circles) or TLR7 KO (open circles) memory B cell transfer. (F,G) ELISPOT assays were used to determine the number
(F) of Qβ specific PCs and the spot diameter (G) in the spleen and BM on day 5 after WT (black shapes) or TLR7 KO (open shapes) memory B cell transfer and
challenge with Qβ-RNA, Qβ-PGA, or Qβ-CpG, respectively. Mean with SEM. P-values were obtained using an unpaired t-test. *p < 0.05, **p < 0.01, ***p < 0.001,
****p < 0.0001. n = 4 mice per group. Data representative of 2 (B–E) or 1 (F,G) independent experiments.
response. This difference was maintained in the BM but gone
in the spleen by day 21, likely because most secondary PCs had
died by then (Figure 3E). In conclusion, as increased antibody
production and spot size are a hallmark of secondary PCs,
these cells were only generated when WT memory B cells were
transferred, which could receive RNA-mediated TLR7 signals
during their generation and re-stimulation.
To assess whether TLR7 KO memory B cells were competent
to differentiate to secondary PCs, adoptive transfers of WT and
TLR7 KOmemory B cells and challenge with Qβ-RNA, Qβ-PGA,
or Qβ-CpG were performed. Qβ-CpG contained B-type CpG
oligodeoxynucleotides, which trigger myeloid differentiation
primary response 88 (MyD88) signaling in B cells via TLR9.
The memory B cell response toward the three challenge antigens
was determined by ELISPOT at day 5 after challenge. TLR7
KO memory B cells exhibited a reduced capacity to generate
secondary PCs in response to Qβ-RNA and Qβ-CpG challenge,
shown by decreased spot number (Figure 3F) and spot size
(Figure 3G) in the spleen and BM. The spot number and spot
sizes generated were comparable to the ones of WT and TLR7
KO memory B cells challenged in the absence of any TLR
ligand (Qβ-PGA) (Figures 3F,G), which failed to differentiate to
secondary PCs (Figure 2). WT memory B cells on the contrary
differentiated to secondary PCs after reactivation with Qβ-RNA
and Qβ-CpG (Figures 3F,G), indicating that TLR9 stimulation
can compensate for TLR7 when memory B cells were induced
in presence of TLR7 ligands. Consequently, TLR7 signaling is
indispensable during memory B cell priming for imprinting
the ability of secondary PC generation after antigen challenge,
as MyD88 signaling induced by TLR9 stimulation is not able
to compensate for the defect seen after TLR7 KO memory B
cell transfer. Moreover, presence of TLR7 or TLR9 signaling is
sufficient for secondary PC formation after challenge of memory
B cells generated in the presence of TLR7 signaling.
B Cell Intrinsic TLR7 Signaling Is Needed
to Generate Memory B Cells Capable of
Differentiating to Secondary PCs
To test whether TLR7 signaling was intrinsically required in B
cells for secondary PC generation, mixed BM chimeras of JH
knockout (KO) with WT or TLR7 KO BM were generated. TLR7
KO BM chimeras exclusively lack TLR7 in B cells, whereas WT
BM chimera B cells were sufficient for TLR7 in all cells. Two
months after reconstitution, both BM chimeras were immunized
with Qβ-RNA (Figure 4A). MACS purified memory B cells
were transferred into recipient WT mice and challenged with
Qβ-RNA (Figures 3A, 4A). From day 4 after challenge the
anti-Qβ total IgG titer as well as the affinity was significantly
lower when memory B cells from TLR7 deficient BM chimeras
were transferred (Figures 4B,C). The difference was particularly
pronounced before day 9 after challenge, representing the
time span when secondary PCs were dominating the response,
providing the early wave of antibodies. As observed before,
the differences became smaller at later time-points, as the host
response developed (Figures 4B,C).
PC numbers and spot sizes examined in spleen and BM
correlated well with the antibody responses (Figures 4B–E).
After transfer of TLR7 KO BM chimera memory B cells,
PC numbers in the spleen were significantly lower compared
to WT BM chimera memory B cell transfer at day 5 after
challenge. This difference was absent 21 days after challenge,
again indicating that secondary PCs are short-lived (Figure 4D).
Moreover, spot diameters, which correlate with the amount of
antibodies produced by PCs, were smaller in spleen and BM at
day 5 after challenge, when TLR7-deficient BM chimera memory
B cells were transferred compared toWT BM chimera memory B
cells (Figure 4E). Taken together, the data presented here clearly
demonstrate that RNA and TLR7 signaling are required in a
B cell intrinsic fashion for the generation of memory B cells
and their differentiation to secondary PCs, which are capable to
produce vast amounts of high affinity antibodies early during
secondary responses.
DISCUSSION
B cell responses are controlled and regulated at multiple levels. As
a key step, B cell specificity is cross-checked by available cognate
T cell help and the presence of innate stimuli indicative of an
infection. This is exemplified by the primary B cell response
against viruses where specificity alone is driving the initial
response by efficient cross-linking of BCRs by the repetitive viral
surface (51). This results in a Th cell independent IgM response,
which is, however, short-lived. Only the presence of cognate
T cell help results in a GC response and isotype-switching.
In this way, the immune system validates the BCR-signals by
the presence of Th cells specific for the same antigen, which
indicates that the recognized antigen is non-self. Presence of
PAMPs, in particular TLR-ligands, is a second checkpoint, which
implies that the antigen is not only non-self but most likely an
infectious agent. This results in augmented antibody and Th cell
responses. Here we demonstrate that TLR-signals, in particular
TLR7, are also key in secondary B cell responses as they cause the
differentiation of a subset of memory B cells capable to rapidly
differentiate into secondary PCs upon re-exposure to the same
antigen plus TLR7-ligand.
The adaptive immune system is confronted with the choice
between speed and specificity. As clonal selection and, in the case
of B cells, hypermutation need time to develope, high specificity
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FIGURE 4 | B cell intrinsic TLR7 signaling is needed to generate memory B cells capable of producing secondary PCs. (A) Mixed BM chimeric mice with 20% WT or
TLR7 KO and 80% JH KO BM were generated. Eight weeks after reconstitution the WT and TLR7 KO chimeras were immunized with 50 µg Qβ-RNA. Memory B cells
from BM chimeric mice were transferred into congenic Ly5.1 recipients after 8 weeks. Recipient mice were challenged with 50 µg Qβ-RNA 24 h after the adoptive
transfer. (B) The anti-Qβ total IgG titer in the serum after WT chimera (black squares) or TLR7 KO chimera (open circles) memory B cell transfer was determined by
ELISA. (C) The avidity index of antibodies from sera generated after WT chimera (black circles) or TLR7 KO chimera (open circles) memory B cell transfer and
challenge was calculated after performing a modified ELISA. ELSIPOT assays of splenocytes and BM cells were performed to determine PC number (D) and spot
diameter (E) 5 and 21 days after WT chimera (black circles) or TLR7 KO chimera (open circles) transfer and challenge. Mean with SEM. P-values were obtained using
an unpaired t-test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. n = 4 mice per group. Data representative of two independent experiments.
comes at the cost of time. As many pathogens may be fatal
within a week, highly specific antibody responses would be too
late to provide protection (52). Broadly cross-reactive antibody
responses, on the other hand, always carry the risk of non-desired
recognition of self-antigens. The solution the immune system
found during primary responses is the early and rapid generation
of poly-reactive IgM antibodies, which are especially potent at
recognizing repetitive surfaces due to their deca-valence. To
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balance the potential of IgM antibodies to cross-react, these
responses are, however, short-lived and eventually replaced by
highly specific bivalent IgG antibodies, which are controlled by
cognate T cell help and presence of TLR-ligands.
We demonstrate here that secondary antibody responses
may follow a similar pattern. Pre-existing, TLR7- and Th cell
experienced memory B cells differentiate rapidly to secondary
PCs, which produce large amounts of high affinity IgG
antibodies. This differentiation occurs without direct interaction
with cognate Th cells (12) but needs again the presence of
RNA or CpG oligodeoxynucleotides to engage TLR7/9 signaling
to ensure presence of an infectious agent. However, since
the pathogen may have evolved over time, these high affinity
IgG antibodies may primarily recognize the original pathogen
rather than the current version. For this reason, similar as the
IgM antibodies generated during the primary response, this
early wave of secondary IgG antibodies is replaced by a more
specific second wave of antibodies derived from naïve B cells,
which again will require presence of Th and TLR7-ligands for
optimal specificity.
The present data further underscore the importance of RNA-
sensing in B cells. We and others have previously shown that
TLR signaling in B cells drives primary B cell responses and is,
at least for viral particles, more important than TLR7 signaling
in DCs (16–19). Here we extend these findings to secondary
B cell responses and demonstrate that B cell-intrinsic TLR7-
signaling is essential for imprinting the ability to differentiate
to secondary PCs, as vaccination with VLPs deprived of RNA
induces affinity matured memory B cells which lack the potential
to generate secondary PCs. Moreover, this signaling pathway
is also key for driving the differentiation of these secondary
PCs from memory B cells. Hence, TLR7 signaling in B cells
is essential for the shaping of both primary and secondary B
cell responses. These data have obvious implications for vaccine
design as the major vaccines based on virus-like particles, those
against hepatitis B virus, human papilloma virus and malaria do
not package RNA. Future vaccine platforms may therefore be
based on VLPs incorporating RNA in order to allow formation of
memory B cells capable of differentiating into secondary PCs to
provide the first wave of rapidly produced protective antibodies
during re-infection.
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